LEXINGTON, Mass.--(BUSINESS WIRE)--Jun. 19, 2014--
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the
Company will present at the 9th Annual JMP Securities
Healthcare Conference on Wednesday, June 25, at 2:30 p.m. (EDT) in New
A live audio webcast
and replay of the presentation will be available on the "Investors"
section of the Company's website, www.syntapharma.com.
About Synta Pharmaceuticals
Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on
discovering, developing, and commercializing small molecule drugs to
extend and enhance the lives of patients with severe medical conditions,
including cancer and chronic inflammatory diseases. Synta has a unique
chemical compound library, an integrated discovery engine, and a diverse
pipeline of clinical- and preclinical-stage drug candidates with
distinct mechanisms of action and novel chemical structures. All Synta
drug candidates were invented by Synta scientists using our compound
library and discovery capabilities. For more information, please visit www.syntapharma.com.
Source: Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp.
Steven Bernitz, 781-541-7250
Vice President, Corporate Development
Andrea Rabney, 212-600-1494
Eliza Schleifstein, 917-763-8106